Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1

Drug Metabolism and Disposition

Volumn 35, Issue 5, 2007, Pages 740-746

  Ung, Din ^a   Nagar, Swati ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOENZYME; APIGENIN; BACULOVIRUS VECTOR; CHRYSIN; EPICATECHIN; POLYPHENOL; QUERCETIN; RESVERATROL; SULFOTRANSFERASE; SULFOTRANSFERASE 1 A1; SULFOTRANSFERASE 1 E1; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG METABOLISM; ENZYME INACTIVATION; ENZYME KINETICS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAMMAL CELL; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SULFATION;

APIGENIN; ARYLSULFOTRANSFERASE; CATECHIN; CELL PROLIFERATION; DIET; FLAVONOIDS; HUMANS; KINETICS; PHENOLS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUERCETIN; RECOMBINANT PROTEINS; STILBENES; SULFATES; SULFOTRANSFERASES; TUMOR CELLS, CULTURED;

HEXAPODA; MAMMALIA;

EID: 34247402170     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.013987     Document Type: Article

References (41)

1. Adjei AA, Thomae BA, Prondzinski JL, Eckloff BW, Wieben ED, and Weinshilboum RM (2003) Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics. Br J Pharmacol 139:1373-1382.
2. Anderson R and Weinshilboum R (1980) Phenolsulfotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clin Chim Acta 103:79-90.
3. Bamber D, Fryer A, Strange R, Elder J, Deakin M, Rajagopal R, Fawole A, Gilissen R, Campbell F, and Coughtrie M (2001) Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colon cancer. Pharmacogenetics 11:679-685.
4. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature (Lond) 444:337-342.
5. Baur JA and Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506.
6. Beecher G (2003) Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133:3248S-3254S.
7. Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF, and Mabry TJ (2002) Flavonoid effects relevant to cancer. J Nutr 132:3482S-3489S.
8. Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, et al. (2005) Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev 14:1090-1095.
9. Coughtrie M (2002) Sulfation through the looking glass - recent advances in sulfotransferase research for the curious. Pharmacogenomics J 2:297-308.
10. De Santi C, Pietrabissa A, Spisni R, Mosca F, and Pacifici GM (2000) Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30:857-866.
11. Galijatovic A, Otake Y, Walle UK, and Walle T (1999) Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica 29:1241-1256.
12. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, and McManus ME (2006) Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90:5-22.
13. Geese W and Raftogianis R (2001) Biochemical characterization and tissue distribution of human SULT2B1. Biochem Biophys Res Commun 288:280-289.
14. Harrington WR, Sengupta S, and Katzenellenbogen BS (2006) Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology 147:3843-3850.
15. Harris RM, Wood DM, Bottomley L, Blagg S, Owen K, Hughes PJ, Waring RH, and Kirk CJ (2004) Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab 89:1779-1787.
16. Jones AL, Hagen M, Coughtrie MW, Roberts RC, and Glatt H (1995) Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochem Biophys Res Commun 208:855-862.
17. Kim YA, Choi BT, Lee YT, Park DI, Rhee SH, Park KY, and Choi YH (2004) Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep 11:441-446.
18. Manach C, Scalbert A, Morand C, Remesy C, and Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727-747.
19. Miksits M, Maier-Salamon A, Aust S, Thalhammer T, Reznicek G, Kunert O, Haslinger E, Szekeres T, and Jaeger W (2005) Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35:1101-1119.
20. Nagar S, Remmel R, Hebbel R, and Zimmerman C (2004) Metabolism of opioids is altered in liver microsomes of sickle cell transgenic mice. Drug Metab Dispos 32:98-104.
21. Nagar S, Walther S, and Blanchard RL (2006) Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol Pharmacol 69:2084-2092.
22. Nowell SA, Ahn J, Rae JM, Scheys JO, Trovato A, Sweeney C, MacLeod SL, Kadlubar FF, and Ambrosone CB (2005) Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat 91:249-258.
23. Otake Y, Nolan AL, Walle UK, and Walle T (2000) Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J Steroid Biochem Mol Biol 73:265-270.
24. Pai TG, Suiko M, Sakakibara Y, and Liu MC (2001) Sulfation of flavonoids and other phenolic dietary compounds by the human cytosolic sulfotransferases. Biochem Biophys Res Commun 285:1175-1179.
25. Raftogianis RB, Her C, and Weinshilboum RM (1996) Human phenol sulfotransferase pharmacogenetics: STP1 gene cloning and structural characterization. Pharmacogenetics 6:473-487.
26. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, and Weinshilboum RM (1997) Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239:298-304.
27. Raftogianis RB, Wood TC, and Weinshilboum RM (1999) Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 58:605-616.
28. Seth P, Lunetta K, Bell D, Gray H, Nasser S, Rhei E, Kaelin C, Iglehart D, Marks J, Garber J, et al. (2000) Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 60:6859-6863.
29. Shatalova EG, Walther SE, Favorova OO, Rebbeck TR, and Blanchard RL (2005) Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study. Breast Cancer Res 7:R909-R921.
30. Tang D, Rundle A, Mooney L, Cho S, Schnabel F, Estabrook A, Kelly A, Levine R, Hibshoosh H, and Perera F (2003) Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Treat 78:217-222.
31. Ung D and Nagar S (2006a) Analysis of dietary flavonoid sulfation and anti-proliferative effect with purified recombinant protein and MCF-7 cells stably expressing human SULT1A1 or SULT1E1, in 14th North American ISSX Meeting, 2006 Oct 22-26; Rio Grande, Puerto Rico. International Society for the study of Xenobiotics, Washington, DC.
32. Ung D and Nagar S (2006b) Variable sulfonation of dietary flavonoids by recombinant human SULT1A1 and SULT1E1, in 2006 AAPS Annual Meeting and Exposition, 2006; 2006 Oct 28-Nov 3; San Antonio TX. American Association of Pharmaceutical Scientists, Arlington, VA.
33. Varin L, Barron D, and Ibrahim RK (1987) Enzymatic assay for flavonoid sulfotransferase. Anal Biochem 161:176-180.
34. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, and Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382.
35. Walle UK, Galijatovic A, and Walle T (1999) Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem Pharmacol 58:431-438.
36. Wang Y, Spitz M, Tsou AM-H, Zhang K, Makan N, and Wu X (2002) Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer 35:137-142.
37. Wen X and Walle T (2006) Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 36:387-397.
38. Williams J, Stone E, Fakis G, Johnson N, Cordell J, Meinl W, Glatt H, Sim E, and Phillips D (2001) N-Acetyltransferases, sulfotransferases, and heterocyclic amine activation in the breast. Pharmacogenetics 11:373-388.
39. Wu MT, Wang YT, Ho CK, Wu DC, Lee YC, Hsu HK, Kao EL, and Lee JM (2003) SULT1A1 polymorphism and esophageal cancer in males. Int J Cancer 103:101-104.
40. Zhang S, Yang X, and Morris ME (2004) Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol 65:1208-1216.
41. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, and Folsom AR (2001) Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:89-94.